Benedetta Peruzzi

2004-2006 Urologic Oncology Branch National Cancer Institue-NIH 
 2007- Azienda Ospedaliero Universitaria Careggi 
"Benedetta Peruzzi"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mazzoni A, Salvati L, Maggi L, et al. (2020) Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. The Journal of Clinical Investigation. 130: 4694-4703
Buoro S, Peruzzi B, Fanelli A, et al. (2018) Two-site evaluation of the diagnostic performance of the Sysmex XN Body Fluid (BF) module for cell count and differential in Cerebrospinal Fluid. International Journal of Laboratory Hematology. 40: 26-33
Cavone L, Felici R, Lapucci A, et al. (2015) Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS rebound. Brain, Behavior, and Immunity. 50: 78-86
Cecchi F, Pajalunga D, Fowler CA, et al. (2012) Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signaling. Cancer Cell. 22: 250-62
Cecchi F, Pajalunga D, Fowler A, et al. (2011) A hepatocyte growth factor antagonist engineered by site-directed mutagenesis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 10528
Peruzzi B, Araten DJ, Notaro R, et al. (2010) The use of PIG-A as a sentinel gene for the study of the somatic mutation rate and of mutagenic agents in vivo. Mutation Research. 705: 3-10
Cecchi F, Pajalunga D, Rabe DC, et al. (2010) Abstract 342: A hepatocyte growth factor antagonist engineered by disruption of heparan sulfate binding Cancer Research. 70: 342-342
Giubellino A, Shi ZD, Jenkins LM, et al. (2008) Selectivity and mechanism of action of a growth factor receptor-bound protein 2 SRC homology 2 domain binding antagonist. Journal of Medicinal Chemistry. 51: 7459-68
Peruzzi B, Bottaro DP. (2006) Beta-catenin signaling: linking renal cell carcinoma and polycystic kidney disease. Cell Cycle (Georgetown, Tex.). 5: 2839-41
Peruzzi B, Athauda G, Bottaro DP. (2006) The von Hippel-Lindau tumor suppressor gene product represses oncogenic beta-catenin signaling in renal carcinoma cells. Proceedings of the National Academy of Sciences of the United States of America. 103: 14531-6
See more...